# BD Veritor™ At-Home and BD Veritor™ Professional

> **NCT05352581** · — · COMPLETED · sponsor: **Becton, Dickinson and Company** · enrollment: 1146 (actual)

## Conditions studied

- Upper Respiratory Infection

## Interventions

- **DIAGNOSTIC_TEST:** BD Veritor At-Home
- **DIAGNOSTIC_TEST:** BD Veritor Professional

## Key facts

- **NCT ID:** NCT05352581
- **Lead sponsor:** Becton, Dickinson and Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-07-21
- **Primary completion:** 2023-03-09
- **Final completion:** 2023-04-14
- **Target enrollment:** 1146 (ACTUAL)
- **Last updated:** 2023-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05352581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05352581, "BD Veritor™ At-Home and BD Veritor™ Professional". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05352581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*